Rainbow Children's [RAINBOW] vs Alivus Life Sciences [GLS] Detailed Stock Comparison

Rainbow Children's Medicare Pvt. Ltd.

NSE
Loading...

Alivus Life Sciences Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Rainbow Children's Medicare Pvt. Ltd. wins in 2 metrics, Alivus Life Sciences Ltd. wins in 16 metrics, with 0 ties. Alivus Life Sciences Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Rainbow Children's Medicare Pvt. Ltd. Alivus Life Sciences Ltd. Better
P/E Ratio (TTM) 50.33 31.45 Alivus Life Sciences Ltd.
Price-to-Book Ratio 8.50 4.87 Alivus Life Sciences Ltd.
Debt-to-Equity Ratio 53.24 0.01 Alivus Life Sciences Ltd.
PEG Ratio 8.95 2.05 Alivus Life Sciences Ltd.
EV/EBITDA 28.65 17.60 Alivus Life Sciences Ltd.
Profit Margin (TTM) 15.97% 53.28% Alivus Life Sciences Ltd.
Operating Margin (TTM) 24.10% 28.97% Alivus Life Sciences Ltd.
EBITDA Margin (TTM) 24.10% 28.97% Alivus Life Sciences Ltd.
Return on Equity 16.50% 20.19% Alivus Life Sciences Ltd.
Return on Assets (TTM) 10.24% 16.52% Alivus Life Sciences Ltd.
Free Cash Flow (TTM) $2.50B $2.85B Alivus Life Sciences Ltd.
Dividend Yield 0.40% N/A N/A
1-Year Return -3.98% 1.86% Alivus Life Sciences Ltd.
Price-to-Sales Ratio (TTM) 7.98 5.66 Alivus Life Sciences Ltd.
Enterprise Value $134.20B $120.91B Rainbow Children's Medicare Pvt. Ltd.
EV/Revenue Ratio 8.32 5.53 Alivus Life Sciences Ltd.
Gross Profit Margin (TTM) 86.46% 55.55% Rainbow Children's Medicare Pvt. Ltd.
Revenue per Share (TTM) $159 $178 Alivus Life Sciences Ltd.
Earnings per Share (Diluted) $25.23 $38.38 Alivus Life Sciences Ltd.
Beta (Stock Volatility) 0.09 N/A N/A

Rainbow Children's Medicare Pvt. Ltd. vs Alivus Life Sciences Ltd. Stock Performance Analysis

Loading Price Chart...

RAINBOW
GLS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Rainbow Children's Medicare Pvt. Ltd.3.93%5.61%6.17%26.89%4.16%7.85%
Alivus Life Sciences Ltd.1.51%5.94%1.62%14.70%16.55%16.96%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Rainbow Children's Medicare Pvt. Ltd.-3.98%44.50%199.08%199.08%199.08%199.08%
Alivus Life Sciences Ltd.1.86%71.75%38.02%38.02%38.02%38.02%

Performance & Financial Health Analysis: Rainbow Children's Medicare Pvt. Ltd. vs Alivus Life Sciences Ltd.

MetricRAINBOWGLS
Market Information
Market Cap i₹128.63B₹123.75B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i144,33592,971
90 Day Avg. Volume i253,94772,770
Last Close₹1,418.60₹1,061.50
52 Week Range₹1,084.00 - ₹1,645.70₹819.00 - ₹1,148.40
% from 52W High-13.80%-7.57%
All-Time High₹1,709.60 (Nov 25, 2024)₹1,335.10 (Sep 16, 2024)
% from All-Time High-17.02%-20.49%
Growth Metrics
Quarterly Revenue Growth0.12%0.27%
Quarterly Earnings Growth0.06%0.12%
Financial Health
Profit Margin (TTM) i0.16%0.53%
Operating Margin (TTM) i0.24%0.29%
Return on Equity (TTM) i0.17%0.20%
Debt to Equity (MRQ) i53.240.01
Cash & Liquidity
Book Value per Share (MRQ)₹149.48₹207.22
Cash per Share (MRQ)₹54.57N/A
Operating Cash Flow (TTM) i₹3.63B₹4.70B
Levered Free Cash Flow (TTM) i₹2.43B₹4.71B
Dividends
Last 12-Month Dividend Yield i0.40%N/A
Last 12-Month Dividend i₹6.00₹0.00

Valuation & Enterprise Metrics Analysis: Rainbow Children's Medicare Pvt. Ltd. vs Alivus Life Sciences Ltd.

MetricRAINBOW (Apr 24, 2026)GLS (Apr 07, 2026)
Price Ratios
P/E Ratio (TTM) i50.3331.45
Forward P/E i40.4322.31
PEG Ratio i8.952.05
Price to Sales (TTM) i7.985.66
Price to Book (MRQ) i8.504.87
Market Capitalization
Market Capitalization i₹128.63B₹123.75B
Enterprise Value i₹134.20B₹120.91B
Enterprise Value Metrics
Enterprise to Revenue i8.325.53
Enterprise to EBITDA i28.6517.60
Risk & Other Metrics
Beta i0.09N/A
Book Value per Share (MRQ) i₹149.48₹207.22

Financial Statements Comparison: Rainbow Children's Medicare Pvt. Ltd. vs Alivus Life Sciences Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricRAINBOW (2025)GLS (2024)
Revenue/Sales i14.95B21.85B
Cost of Goods Sold i1.95B10.21B
COGS % of Revenue i13.0%46.7%
Gross Profit i13.00B11.64B
Gross Margin i87.0%53.3%
Research & Development iN/AN/A
Operating Income (EBIT) i3.56B6.22B
Operating Margin i23.8%28.5%
EBITDA i5.05B6.87B
EBITDA Margin i33.8%31.4%
Pre-Tax Income i3.30B6.31B
Pre-Tax Income % of Revenue i22.1%28.9%
Income Tax i857.74M1.60B
Income Tax % of Revenue i5.7%7.3%
Net Income (Profit) i2.44B4.71B
Profit Margin i16.3%21.6%

Balance Sheet & Liquidity Metrics

MetricRAINBOW (2025)GLS (2024)
Cash & Equivalents i202.55M3.01B
Total Current Assets i8.22B19.16B
Total Current Assets % of Revenue i55.0%87.7%
Total Current Liabilities i1.51B4.39B
Total Current Liabilities % of Revenue i10.1%20.1%
Long-Term Debt i7.42B147.61M
Long-Term Debt % of Revenue i49.6%0.7%
Total Shareholders Equity i14.75B23.32B
Retained Earnings i9.57B12.92B
Retained Earnings % of Revenue i64.0%59.1%
Property, Plant & Equipment i2.55B7.95B

Cash Flow Statement Comparison

MetricRAINBOW (2025)GLS (2024)
Operating Cash Flow i3.63B4.70B
Operating Cash Flow % of Revenue i24.3%21.5%
Capital Expenditures i-1.46B-1.29B
Free Cash Flow i2.50B2.85B
FCF Margin i16.7%13.0%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricRAINBOWGLS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i101.44M122.53M
Float Shares i43.02MN/A
% Held by Insiders i53.77%N/A
% Held by Institutions i34.17%N/A
% Held by Public i12.06%N/A

Dividend Analysis & Yield Comparison: Rainbow Children's Medicare Pvt. Ltd. vs Alivus Life Sciences Ltd.

MetricRAINBOWGLS
Last 12-Month Dividend i₹6.00₹0.00
Last 12-Month Dividend Yield i0.40%N/A
3-Year Avg Annual Dividend i₹3.67₹18.00
3-Year Avg Dividend Yield i0.28%3.82%
3-Year Total Dividends i₹11.00₹54.00
Ex-Dividend DateJun 27, 2025Oct 17, 2023